Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas
Research
Anticonvulsant Screening
Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research |
NINDS is part of the
National Institutes of
Health
Event |
---|
|
More Information |
---|
|
Objective
The Program that this Announcement describes is one component of the NIH Roadmap Molecular Libraries and Imaging Initiative. It provides $100K of funding in Year 1 (via the R21 mechanism) to develop and characterize assays to novel targets, pathways and cellular phenotypes that can be miniaturized and automated. The objective of the Program is to develop assays that can be used to identify small molecule interactions via high-throughput screening (HTS) of small molecular compound libraries, and to chemically optimize these active compounds as molecular probes. For this reason, the Program provides rapid “Fast-Track” access, and $25K of additional funding, for HTS-ready assay projects that enter the Roadmap Molecular Library Screening Center Network (MLSCN) in Year 2 of the award.
Assay Format
All applications should provide a rationale for how the availability of a small molecule molecular probe would add a pharmacological dimension to their work that is not currently possible. In addition, Investigators should define the attributes to be captured in the design of this probe, and provide a plan for developing and characterizing assays that could be used to identify small molecules with essential probe attributes from a large diversity collection of >300,000 small molecules. Emphasis will be placed on the screening of targets for which selective and potent small molecule modulators are not currently available.
Particularity of the program
The overall goal of the Roadmap Molecular Library Initiative is to promote the development of small molecule pharmacological tools, and to also facilitate the creation of a PubChem database matching biological assays (for targets, pathways or phenotypes) to small molecules that have activity in these assays. This is being accomplished through the creation of the MLSCN, a national network of 10 high-throughput Screening Centers.
The Assay Development for HTS Program described by PAR-08-024 provides the funding necessary to translate assays from the lab bench into formats that can be used by the MLSCN Centers, and thus acts to promote the first necessary step required for molecular probe development.
It is expected that 40-50 assay development projects will be funded (for $8 million), in response to two receipt dates each year for the Assay Development for HTS Program.
The next application receipt date is April 22, 2008.
Additional Information
Notice of Opportunity for Fast Track Entry of Assay Development Projects into the Roadmap Molecular Libraries Screening Center
Network. [Summary]
Release Date: August 15, 2007
Announcement Number: NOT-RM-07-012
Funding Contact: Mark Scheideler Ph.D.
Links to the Roadmap Molecular Libraries and Blueprint for Neuroscience Research Initiatives
Institute Contact to the Program:
Mark Scheideler, Ph.D.
Program Director, Molecular Libraries
Technology Development, NINDS
National Institutes of Health
6001 Executive Blvd, Room 2107
Bethesda, Maryland 20892-9527
Email: scheidelerm@ninds.nih.gov
Last updated June 20, 2008